C

CrystalGenomics Inc
KOSDAQ:083790

Watchlist Manager
CrystalGenomics Inc
KOSDAQ:083790
Watchlist
Price: 1 347 KRW 1.05% Market Closed
Market Cap: 103.6B KRW

Operating Margin
CrystalGenomics Inc

-227.7%
Current
-302%
Average
-4.7%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-227.7%
=
Operating Profit
-41.3B
/
Revenue
18.1B

Operating Margin Across Competitors

No Stocks Found

CrystalGenomics Inc
Glance View

Market Cap
103.6B KRW
Industry
Biotechnology

CrystalGenomics, Inc. engages in the discovery and development of novel therapeutics. The company is headquartered in Seongnam, Gyeonggi-Do. The company went IPO on 2006-01-06. The firm operates its business through four segments. The Drug Substance Manufacturing segment manufactures and sells drug substances such as anti-inflammatory analgesics, antispasmodics, and asthma treatments. The Finished Drug Manufacturing segment produces and supplies finished drugs such as cephalosporin antibiotics. The Pharmaceutical Research and Development segment is engaged in the provision of clinical trial analysis and technical services, and sales of new drugs. The company also engages in real estate rental business. The Other segment is engaged in the manufacture and sale of hot pats and other household goods.

Intrinsic Value
1 558.78 KRW
Undervaluation 14%
Intrinsic Value
Price
C
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-227.7%
=
Operating Profit
-41.3B
/
Revenue
18.1B
What is the Operating Margin of CrystalGenomics Inc?

Based on CrystalGenomics Inc's most recent financial statements, the company has Operating Margin of -227.7%.

Back to Top